Asbestos Research Today is a free monthly online journal that collates and summarizes the latest research about Asbestos, including details on mesothelioma, lung disease, dangers, effects, risks.

Volume 2 (2005), Issue 2 (February)

1. Pathogenesis of malignant pleural mesothelioma.
   Respirology, 10(1): 2-8. [Abstract] [Full-text]
2. Podoplanin as a marker for mesothelioma.
   Pathol Int, 55(2): 83-6. [Abstract] [Full-text]
3. Asbestos exposure from gaskets during disassembly of a medium duty diesel engine.
   Regul Toxicol Pharmacol, 41(2): 113-21. [Abstract] [Full-text]
4. Cancer mortality in a cohort of asbestos textile workers.
   Br J Cancer, 92(3): 580-6. [Abstract] [Full-text]
5. The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050.
   Br J Cancer, 92(3): 587-93. [Abstract] [Full-text]
6. Production of nitric oxide elevates nitrosothiol formation resulting in decreased glutathione in macrophages exposed to asbestos or asbestos substitutes.
   Arch Toxicol, 79(2): 83-9. [Abstract] [Full-text]
7. Peritoneal biphasic mesothelioma in a dog.
   J Vet Med A Physiol Pathol Clin Med, 52(1): 22-5. [Abstract] [Full-text]
8. Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids.
   Diagn Cytopathol, 32(3): 151-5. [Abstract] [Full-text]
9. Differentiation of mesothelioma from adenocarcinoma in serous effusions: the role of hyaluronic acid and CD44 localization.
   Diagn Cytopathol, 32(3): 145-50. [Abstract] [Full-text]
10. Image cytometry: an aid for cytological diagnosis of pleural effusions.
    Diagn Cytopathol, 32(3): 173-6. [Abstract] [Full-text]
11. The value of epithelial membrane antigen expression in separating benign mesothelial proliferation from malignant mesothelioma: a comparative study.
    Diagn Cytopathol, 32(3): 156-9. [Abstract] [Full-text]
12. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
    Diagn Cytopathol, 32(3): 137-44. [Abstract] [Full-text]
13. The combination of CEA, EMA, and BerEp4 and hyaluronan analysis specifically identifies 79% of all histologically verified mesotheliomas causing an effusion.
    Diagn Cytopathol, 32(3): 160-6. [Abstract] [Full-text]
14. Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection.
    Oncogene, 24(7): 1302-8. [Abstract] [Full-text]
15. Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy.
    Cancer, 103(4): 839-49. [Abstract] [Full-text]
16. Granulocyte-colony stimulating factor- and interleukin 6-producing diffuse deciduoid peritoneal mesothelioma.
    Mod Pathol, 18(3): 446-50. [Abstract] [Full-text]
17. Primary malignant mesothelioma of the peritoneum: a clinical and immunohistochemical study.
    Gynecol Oncol, 96(3): 860-4. [Abstract] [Full-text]
18. Inhibition of proliferation, migration, and matrix metalloprotease production in malignant mesothelioma cells by tyrosine kinase inhibitors.
    Neoplasia, 6(6): 705-12. [Abstract] [Full-text]
19. Chemotherapy options and new advances in malignant pleural mesothelioma.
    Ann Oncol, 16(3): 345-51. [Abstract] [Full-text]
20. Granulocyte colony-stimulating factor-producing malignant pleural mesothelioma with the expression of other cytokines.
    Int J Clin Oncol, 10(1): 58-62. [Abstract] [Full-text]

© 2004-2008 Asbestos Research Today. All Rights Reserved.